Freeze-drying protein formulations above their collapse temperatures: Possible issues and concerns

American Pharmaceutical Review

Volumn 14, Issue 3, 2011, Pages 50-54

  Johnson, Robert ^a   Lewis, Lavinia ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXCIPIENT; MANNITOL; PROTEIN; SUCROSE;

DRUG ACTIVITY; DRUG FORMULATION; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; HIGH TEMPERATURE; MOISTURE; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN STABILITY; PROTEIN STRUCTURE; QUALITY CONTROL; REVIEW; STRUCTURE ANALYSIS; TEMPERATURE DEPENDENCE;

EID: 79955835673     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. S. Rambhatla, J. Obert, S. Luthra, C Bhugra, M. Pikal. 2005. Cake shrinkage during freeze drying: A combined experimental and theoretical study. Pharm Dev Technol 1:33-40. (Pubitemid 40315527)
2. R. Johnson, M. Oldroyd, S. Ahmed, H. Gieseler, L. Lewis. 2010. Use of Manometric Temperature Measurements (MTM) to characterize the freeze-drying behavior of amorphous protein formulations. J Pharm Sci 99:2863-2873.
3. W. Wang. 2000. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203:1-60. (Pubitemid 30627625)
4. A. MacKenzie. 1975. Collpase during freeze drying - Qualitative and quantitative aspects. In: S. Goldblith, L. Rey, W. Rothmayr, eds. Freeze drying and advanced food technology. London: Academic Press.
5. R. Johnson, C. Kirchhoff, H. Gaud. 2002. Mannitol-sucrose mixtures - Versatile formulations for protein lyophilization. J Pharm Sci 91:914-922. (Pubitemid 34640915)
6. K. Chatterjee, E. Shalaev, R. Suryanarayanan. 2005. Partially crystalline systems in lyophilization: II. Withstanding collapse at high primary drying temperatures and impact on protein activity recovery. J Pharm Sci 94:809-820. (Pubitemid 40577313)
7. K. Schersch, O. Betz, P. Garidel, S. Muehlau, S. Bassarab, G. Winter. 2010. Systematic investigation of the effect lyophilizate collapse on pharmaceutically relevant proteins I: Stability after freeze-drying. J Pharm Sci 99:2256-2278.
8. J. Colandene, L. Maldonado, A. Creagh, J. Vrettos, K. Goad, T. Spitznagel. 2007. Lyophilization cycle development for a high-concentration monoclonal antibody formulation lacking a crystalline bulking agent. J Pharm Sci 96:1598-1608. (Pubitemid 46953774)
9. E. Meister, H. Gieseler. 2009. Freeze-dry microscopy of protein/sugar mixtures: Drying behavior, interpretation of collapse temperatures and a comparison to corresponding glass transition data. J Pharm Sci 98:3072-3087.
10. N. Milton, M. Pikal, M. Roy, S. Nail. 1997. Evaluation of manometric temperature measurement as a method of monitoring product temperature during lyophilization. J Parenteral Sci Technol 51:7-15.
11. D. Overcashier, T. Patapoff, C. Hsu. 1999. Lyophilization of protein formulations in vials: Investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse. J Pharm Sci 88:688-695. (Pubitemid 29325995)
12. F. Fonseca, S. Passot, O. Cunin, M. Marin. 2004. Collapse temperature of freeze-dried Lactobacillus bulgaricus suspensions and protective media. Biotechnol Prog 20:229-238. (Pubitemid 38204193)
13. A. Abdul-Fattah, V. Truong-Le, L. Yee, L. Nguyen, D. Kolonia, M. Cicerone, M. Pikal. 2007. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): Stability of a monoclonal antibody. J Pharm Sci 96:1983-2008. (Pubitemid 47280096)
14. A. Abdul-Fattah, V. Truong-Le, L. Yee, E. Pan, Y. Ao, D. Kolonia, M. Cicerone, M. Pikal. 2007. Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability (I): Stability of a vaccine. Pharm Res 24:715-727. (Pubitemid 46415554)
15. A. Abdul-Fattah, D. Kolonia, M. Pikal. 2007. The challenge of drying method selection for protein pharmaceuticals: Product quality implications. J Pharm Sci 96:1886-1916. (Pubitemid 47280090)
16. A. Parker, S. Rigby-Singleton, M. Perkins, D. Bates, D. LeRoux, C. Roberts, C. Madden-Smith, L. Lewis, D. Teagarden, R. Johnson, S. Ahmed. 2010. Determination of the influence of primary drying rates on the microscale structural attributes and physicochemical properties of protein containing lyophilized products. J Pharm Sci 99:4616-4629.
17. S. Tchessalov. 2011. Exploring the collapse phenomenon during lyophilization: When is collapse acceptable? CHI PepTalk Conference on Lyophilization and Spray Drying, San Diego.
18. L. Lewis, R. Johnson, M. Oldroyd, S. Ahmed, L. Joseph, I. Saracovan, S. Sinha. 2010. Characterizing the freeze-drying behavior of model protein formulations. AAPS PharmSci Tech 11:1580-1590.
19. A. Dong, S. Prestrelski, S. Allison, J. Carpenter. 1995. Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation. J Pharm Sci 84:415-424.
20. S. Luthra, J. Obert, D. Kalonia, M. Pikal, 2007. Investigation of drying stresses on proteins during lyophilization : Differentiation between primary and secondary-drying stresses on lactate dehydrogenase using a humidity controlled mini freeze-dryer. J Pharm Sci 96:61-70. (Pubitemid 46087339)
21. S. Bassarab, O. Betz, P. Garidel, S. Muhlau, K. Schersch, G. Winter. 2007. Scrutinizing the effect of collapse during lyophilization. AAPS Annual Meeting Abstract.
22. S. Jiang, S. Nail. 1998. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm 45:249-257. (Pubitemid 28270813)
23. D. Wang, J. Hey, S. Nail. 2004. Effect of collapse on the stability of freeze-dried recombinant Factor VIII and α-amylase. J Pharm Sci 93:1253-1263. (Pubitemid 38529698)
24. S. Passot, F. Fonseca, N. Barbouche, M. Marin. 2007. Effect of product temperature during primary drying on the long-term stability of lyophilized proteins. Pharm Dev Tech 12:543-553.
25. B. Lueckel, B. Helk, D. Bodmer, H. Leuenberger. 1998. Effects of formulation and process variables on the aggregation of freeze-dried interluekin-6 (IL-6) after lyophilization and on storage. Pharm Dev Technol 3:337-346. (Pubitemid 28410361)